The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 26, 2021

Filed:

Nov. 11, 2015
Applicant:

Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;

Inventors:

Tomoyuki Igawa, Shizuoka, JP;

Shojiro Kadono, Kanagawa, JP;

Naoka Hironiwa, Shizuoka, JP;

Mika Sakurai, Shizuoka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C40B 40/10 (2006.01); A61K 39/395 (2006.01); C40B 30/04 (2006.01); C07K 16/42 (2006.01); C07K 16/28 (2006.01); C40B 40/08 (2006.01); C12N 15/09 (2006.01);
U.S. Cl.
CPC ...
A61K 39/395 (2013.01); C07K 16/28 (2013.01); C07K 16/2809 (2013.01); C07K 16/2848 (2013.01); C07K 16/2866 (2013.01); C07K 16/2875 (2013.01); C07K 16/2896 (2013.01); C07K 16/42 (2013.01); C12N 15/09 (2013.01); C40B 30/04 (2013.01); C40B 40/08 (2013.01); C40B 40/10 (2013.01); C07K 2317/31 (2013.01); C07K 2317/35 (2013.01); C07K 2317/55 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present inventors have successfully prepared a library consisting essentially of a plurality of antigen-binding molecules differing in sequence from each other, the antigen-binding molecules each comprising an antibody variable region that has binding activity against a first antigen and a second antigen different from the first antigen, but does not bind to the first antigen and the second antigen at the same time. Use of the library of the present invention allows the obtainment of a variable region having enhanced ability to bind to the first antigen and the production of a bispecific antibody against the first antigen and a cancer antigen. Moreover, the present inventors have also successfully prepared an antigen-binding molecule comprising an antibody variable region that has binding activity against three different antigens, but does not bind to these antigens at the same time.


Find Patent Forward Citations

Loading…